[Sponsored] A new white paper from LiveWorld highlights how AI tools for healthcare marketers fall short and what’s needed for more effective marketing strategies. The post How Human-Led AI Improves Healthcare Marketing Intelligence appeared first on MedCity News.
Taya Hailstone has been in remission from childhood Hodgkin lymphoma for five years. But the cancer’s lasting damage to her organs and nerves can make basic tasks, like loading a dishwasher, hard. Still, Montana’s health department decided last year that Hailstone is no longer eligible for low-cost disability health coverage through Medicaid. The department switched…
Amber Bates of Cohutta, Georgia, is one of thousands of people without health insurance in the 14th Congressional District, home to about 765,000 people in the northwestern corner of the state. She and her husband have not had health coverage for the past two years, Bates said, because their employment is unsteady and they earn…
Dr. Brian Miller has seen medical technology regulation from every side — as a hospitalist, a former FDA official, and now an associate professor at Johns Hopkins University, where he leads a research group on market-driven approaches to FDA regulation and Medicare payment policy. In this episode, Chip talks with Miller about what happens when…
Latent’s AI-powered agents analyze patient data and automate administrative tasks such as prior authorizations
By DAVID INTROCASO This is Part 2 of David Introcaso’s review of the attempt by the Biden admin to do something about the massive carbon footprint of the US health care system. If you haven’t read part 1, start here. Discussion Under Secretary Becerra, HHS’s effort to decarbonize healthcare amounted to passive obstructionism or at…
Nara Health’s funding was led by Khosla Ventures, with participation from Long Journey Ventures and Superior Studios. The post Nara Health Secures $14M for Third Party Administration Platform appeared first on MedCity News.
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other rare muscle disorders. The post Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease…
If trust, transparency, and accountability remain core values in medicine, AI governance cannot be left to improvisation. The post Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It appeared first on MedCity News.
This webinar explores how healthcare organizations can leverage AI not just for efficiency but to foster genuine patient engagement and strengthen human connections, emphasizing the importance of patient-centered care.